Gilder Gagnon Howe & Co’s Curis CRIS Stock Holding History

Gilder Gagnon Howe & Co’s Portfolio CRIS Stock Details CRIS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-24	Closed	-$75K	–	401
2021 Q3	$75K	Buy	+24	New	+$75K	﹤0.01%	377

Other funds holding CRIS

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

MCM

M28 Capital Management Stamford, Connecticut $53.8M AUM 28.63% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return

Gilder Gagnon Howe & Co's CRIS Position: Q4 2021 in Review

Gilder Gagnon Howe & Co sold out of Curis (CRIS) in Q4 2021, closing a stake of 24 shares — an estimated $75K sold.

Gilder Gagnon Howe & Co first reported a position in CRIS in Q3 2021 and held it in 1 quarter. The position peaked at $75K in Q3 2021. 128 funds tracked by Wall St. Rank hold CRIS as of Q4 2021.

Gilder Gagnon Howe & Co reported no remaining Curis position as of Q4 2021 after selling out during the quarter.
Gilder Gagnon Howe & Co sold 24 Curis shares in Q4 2021, an estimated $75K.
Gilder Gagnon Howe & Co first reported a position in Curis in Q3 2021 and held it in 1 quarter.
Gilder Gagnon Howe & Co's Curis position peaked at $75K in Q3 2021.
128 funds tracked by Wall St. Rank held Curis as of Q4 2021.

Based on Gilder Gagnon Howe & Co's 13F filing for Q4 2021, filed 14 Feb 2022.